Percheron Therapeutics Ltd - Company Profile
Powered by 
All the data and insights you need on Percheron Therapeutics Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Percheron Therapeutics Ltd Strategy Report
- Understand Percheron Therapeutics Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Percheron Therapeutics Lead Sheet
Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Percheron Therapeutics Ltd’s relevant decision makers and contact details.
A sample of Percheron Therapeutics Lead Sheet data
| Lead Date | Lead Type | Lead Description | Company Name | Drug Name | Therapy Area |
|---|---|---|---|---|---|
| 02 Mar 2023 | GDCTWXYZ | Lorem | Lorem | Lorem | Cardiovascular |
| 22 Nov 2022 | Expected Trial Results | Phase II/III Results Expected in H1-2024 | Antisense Therapeutics Ltd | ATL-1102 | Genetic Disorders |
| 30 Jun 2022 | Rescue Study | This company may need services for their Phase II/III trial Initiation | Antisense Therapeutics Ltd | ATL-1102 | Genetic Disorders |
| 30 Jun 2022 | Expected Trial Initiations | Phase III Trial Initiation Expected on 05-Nov-2022<br/>One quarter of Phase III Trial Initiation for Central Nervous System drugs occur within 4.3 months after positive Phase II Results are announced. Atl-1102's Phase III Trial Initiation is estimated to occur 4.3 months from its positive Phase II Results which were announced on June 28, 2022. | Antisense Therapeutics Ltd | ATL-1102 | Central Nervous System |
Feature
Lead Sheet offers business development users in a Supplier Company, convenient access to leads within the biopharmaceutical industry.
- Lead: Any current or future events that signal a company may need services from another company in the near future.
Depending on the user’s company type, specific events may be considered a lead for the goods or services they provide.
Benefit
Leads within Lead Sheet fall into six major types of occurrences: Trial Events, Regulatory Events, Deals, Insights, New Companies, and Role Changes.
Some of these categories are broken out further to allow users the flexibility to filter to the event types they consider a lead.
Any lead type starting with “Expected” implies that it is a future event sourced from our Catalyst Calendar.
Value
Lead Sheet is a business development tool to help optimize sales efficiency
- What prospective accounts to target
- When and why to target them through actionable leads/opportunities
- Who to reach out to
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer